VP Corporate Development
“We are here to provide patients and their families with the promise of a better tomorrow regardless of geographic boundaries. This is why our teams work relentlessly, every day, across offices, countries and time zones.”
Gil leads all aspects of Medison’s global corporate development activities, including corporate strategy, expansion to new markets, business development and licensing activities.
Before joining Medison, Gil served as VP at Shamrock, a private equity fund. He was also a board member of several Israeli and international companies where he applied his broad experience in business strategy, consulting, corporate finance, private equity and capital markets.
Gil holds an MBA from the Recanati Business School at Tel Aviv University and a BSc from the Technion – Israel Institute of Technology.